Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (61-70 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|June 26, 1998
[Drug clinics. The drug of the month. Alendronate (Fosamax)]A J Scheen
Expert Review of Clinical Pharmacology|June 30, 2025
Progress towards a personalized management of antidiabetic medications in the elderly with type 2 diabetesA J Scheen
Annales D'Endocrinologie|January 5, 2000
[Benefits and limitations of protein diets in obese patients with type 2 diabetes]A J Scheen
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 24, 2010
Cardiovascular risk-benefit profile of sibutramineA J Scheen
Diabetes & Metabolism|January 8, 2011
Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemiaA J Scheen
Acta Clinica Belgica|January 28, 2009
New therapeutic approaches in type 2 diabetesA J Scheen
Revue Medicale De Liege|March 3, 1998
[The controversy apropos of the discovery of insulin. Its history seen from the aspect of philately]A J Scheen
Revue Medicale De Liege|April 24, 2015
[How to initiate, optimise and stop pharmacological treatments: applications in real life]A J Scheen
Revue Medicale De Liege|April 1, 1997
[Particulars about pharmacotherapy in the elderly patient]A J Scheen
Revue Medicale De Liege|June 1, 1997
[Drug of the month. Fluvastatin (Lescol)]A J Scheen
Pageof 79

Showing results (61-70 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|June 26, 1998
[Drug clinics. The drug of the month. Alendronate (Fosamax)]A J Scheen
Expert Review of Clinical Pharmacology|June 30, 2025
Progress towards a personalized management of antidiabetic medications in the elderly with type 2 diabetesA J Scheen
Annales D'Endocrinologie|January 5, 2000
[Benefits and limitations of protein diets in obese patients with type 2 diabetes]A J Scheen
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 24, 2010
Cardiovascular risk-benefit profile of sibutramineA J Scheen
Diabetes & Metabolism|January 8, 2011
Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemiaA J Scheen
Acta Clinica Belgica|January 28, 2009
New therapeutic approaches in type 2 diabetesA J Scheen
Revue Medicale De Liege|March 3, 1998
[The controversy apropos of the discovery of insulin. Its history seen from the aspect of philately]A J Scheen
Revue Medicale De Liege|April 24, 2015
[How to initiate, optimise and stop pharmacological treatments: applications in real life]A J Scheen
Revue Medicale De Liege|April 1, 1997
[Particulars about pharmacotherapy in the elderly patient]A J Scheen
Revue Medicale De Liege|June 1, 1997
[Drug of the month. Fluvastatin (Lescol)]A J Scheen
Pageof 79